ELITE PHARMACEUTICALS INC /NV/ (EVP Operations) sold 21.7% of their position (500K shares) of ELITE PHARMACEUTICALS INC /NV/ on the open market
Open‑market sale worth $262.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/26/2025ACC: 0001493152-25-012347
Officer· EVP Operations
Since Aug 2025
-500K
Net shares
Net seller
$262.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.50M acquired · 3M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−500K
Price / share
$0.52
Trade value
$262.15K
% of position
21.7%
8/22/2025
2.30M→1.80M
Common Stock
Direct
Shares
+2.50M
Price / share
$0.03
Trade value
$75K
% of position
138.9%
8/25/2025
1.80M→4.30M
Total
Net shares
+2M
Net value
-$187.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/22/2025 | S · Sale | −500K | $0.52 | $262.15K | 21.7% | 2.30M | 1.80M |
| Common Stock Direct | 8/25/2025 | M · Option Exercise | +2.50M | $0.03 | $75K | 138.9% | 1.80M | 4.30M |
| Total | +2M | -$187.15K | ||||||
Derivative Transactions1
Stock Options (right to buy)
Direct
Converts to
Common Stock
2.50M shares
Shares
−2.50M
Strike price
0.03
Held after
2.50M
Exercisable
—
8/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) Direct | Common Stock2.50M shares | 8/25/2025 | M · Option Exercise | −2.50M | 0.03 | — | 2.50M |